"Safe and Effective When Used As Directed": The Case of Chronic Use of Opioid Analgesics

Journal of Medical Toxicology

Volumn 8, Issue 4, 2012, Pages 417-423

  Ballantyne, Jane C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Effectiveness; Opioid; Poisoning; Safety

Indexed keywords

NAPROXEN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ROFECOXIB;

ACUTE HEART INFARCTION; ARTHRITIS; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; DRUG EFFICACY; DRUG FATALITY; DRUG MONITORING; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; PATIENT ATTITUDE; PATIENT MONITORING; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 84870679539     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-012-0257-8     Document Type: Review

References (74)

1. Eisenberg E, McNicol ED, Carr DB (2005) Efficacy and safety of opioid agonists in the treatment of neuropathic pain of non-malignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293: 3043-3052.
2. Ng L (1981) New approaches to treatment of chronic pain: a review of multidisciplinary pain clinics and pain centers. NIDA Res Monogr 36.
3. Fingerhut LA, Cox CS (1998) Poisoning mortality, 1985-1995. Public Health Rep 113: 218-233.
4. Paulozzi LJ, Budnitz DS, Xi Y (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15: 618-627.
5. Substance Abuse and Mental Health Services Administration (2004) Narcotic analgesics, 2002 update. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Rockville.
6. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300: 2613-2620.
7. Furlan A, Chaparro L, Irvin E, Mailis-Gagnon A (2011) A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manag 16: 337-351.
8. Noble M, Tregear S, Treadwell J, Shchoelles K (2008) Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 35: 214-228.
9. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM (2010) Opioid prescriptions for chronic pain and overdose. Ann Intern Med 152: 85-92.
10. Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM (2011) Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 5: E13-E22.
11. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC (2011) Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305: 1315-1321.
12. Gomes T, Mamdani M, Dhalla I, Paterson J, Juurlink D (2011) Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 17: 686-691.
13. Paulozzi LJ, Kilbourne E, Shah N, Nolte K, Desai H, Landen M, Harvey W, Loring L (2012) A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 13: 87-95.
14. Braden JB, Russo J, Fan M-Y, Edlund MJ, Martin BC, DeVries A, Sullivan MD (2010) Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 170: 1425-1432.
15. Saunders K, Dunn K, Merrill J, Sullivan M, Weisner C, Braden J, Psaty B, Von Korff M (2009) Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med 25: 310-315.
16. Solomon D, Rassen J, Glynn R, Lee J, Levin R, Schneeweiss S (2010) The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 170: 1968-1978.
17. Miller M, Sturmer T, Azrael D, Levin R, Solomon D (2011) Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc 59: 430-438.
18. Rolita L, Spegman A, Cronstein B (2011) Unintended consequences: increased prescription of narcotic analgesics for OA in the elderly is associated with increased falls and fractures in the post-Vioxx era. ACR/ARHP Annual Scientific Meeting. American College of Rheumatology, Chicago.
19. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz M, Hawkey J, Hochberg M, Kvien T, Schnitzer T (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. NEJM 343: 1520-1528.
20. Mukherjee D, Nissen S, Topol E (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959.
21. Graham D, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray W (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365: 475-481.
22. Ray W, Stein C, Daugherty J, Hall K, Arbogast P, Griffin M (2002) COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360: 1071-1073.
23. Solomon D, Schneeweiss S, Glynn R, Kiyota Y, Levin R, Mogun H, Avorn J (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109: 2068-2073.
24. Topol E (2004) Failing the public health-rofecoxib, Merck, and the FDA. NEJM 351: 1707-1709.
25. Vaithianathan R, Hockey P, Moore T, Bates D (2009) Iatrogenic effects of COX-2 inhibitors in the US population. Drug Saf 32: 335-343.
26. Ballantyne JC, Shin NS (2008) Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 24: 469-478.
27. Portenoy RK, Foley KM (1986) Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 25: 171-186.
28. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM (2010) Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev CD006605.
29. Tennant FS, Robinson D, Sagherian AS, Seecof R (1988) Chronic opioid treatment of intractable non-malignant pain. NIDA Res Monogr 81: 174-780.
30. Zenz M, Strumpf M, Tryba M (1992) Long-term opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 7: 69-77.
31. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK (2010) Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 151: 625-632.
32. Von Korff M (2012) The epidemiology of use of opioids for chronic pain. In Assessment of Analgesic Treatment of Chronic Pain: A Scientific Workshop. US Food and Drug Administration, Bethesda.
33. Kalso E, Edwards JE, Moore RA, McQuay HJ (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112: 372-380.
34. Nuesch E, Rutjes AW, Husni E, Welch V, Juni P (2009) Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev CD003115.
35. Ballantyne JC, Mao J (2003) Opioid therapy for chronic pain. N Engl J Med 349: 1943-1953.
36. Papaleontiou M, Henderson CR Jr, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, Reid MC (2010) Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 58: 1353-1369.
37. Ballantyne JC, LaForge SL (2007) Opioid dependence and addiction in opioid treated pain patients. Pain 129: 235-255.
38. Ballantyne JC, Sullivan MD, Kolody A (2012) Opioid dependence vs addiction: a distinction without a difference? Arch Int Med 13: 1-2.
39. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58: 295-300.
40. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK (2006) Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 125: 172-179.
41. Dillie KS, Fleming MF, Mundt MP, French MT (2008) Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med 21: 108-117.
42. Sjogren P, Gronbaek M, Peuckmann V, Ekholm O (2010) A population-based cohort study on chronic pain: the role of opioids. Clin J Pain 26: 763-769.
43. Franklin GM, Mai J, Wickizer T, Turner JA, Fulton-Kehoe D, Grant L (2005) Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med 48: 91-99.
44. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM (2008) Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort. Spine (Phila Pa 1976) 33: 199-204.
45. Gross DP, Stephens B, Bhambhani Y, Haykowsky M, Bostick GP, Rashiq S (2009) Opioid prescriptions in Canadian workers' compensation claimants: prescription trends and associations between early prescription and future recovery. Spine (Phila Pa 1976) 34: 525-531.
46. Stover BD, Turner JA, Franklin G, Gluck JV, Fulton-Kehoe D, Sheppard L, Wickizer TM, Kaufman J, Egan K (2006) Factors associated with early opioid prescription among workers with low back injuries. J Pain 7: 718-725.
47. Volinn E, Fargo JD, Fine PG (2009) Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain 142: 194-201.
48. Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D (2009) Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 25: 743-751.
49. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD (2011) Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 26: 1450-1457.
50. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD (2010) Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend 112: 90-98.
51. Phifer J, Skelton K, Weiss T, Schwartz AC, Wingo A, Gillespie CF, Sands LA, Sayyar S, Bradley B, Jovanovic T, Ressler KJ (2011) Pain symptomatology and pain medication use in civilian PTSD. Pain 152: 2233-2240.
52. Richardson LP, Russo JE, Katon W, McCarty CA, Devries A, Edlund MJ, Martin BC, Sullivan M (2012) Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. J Adolesc Health 50: 553-558.
53. Schwartz AC, Bradley R, Penza KM, Sexton M, Jay D, Haggard PJ, Garlow SJ, Ressler KJ (2006) Pain medication use among patients with posttraumatic stress disorder. Psychosomatics 47: 136-142.
54. Seal KH, Shi Y, Cohen G, Maguen S, Krebs EE, Neylan TC (2012) Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 307: 940-947.
55. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB (2006) Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 166: 2087-2093.
56. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M (2009) Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 145: 287-293.
57. Ballantyne JC (2011) Opioids around the clock? Pain 152: 1221-1222.
58. Von Korff MR, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C (2011) Time-scheduled versus pain-contingent opioid dosing in chronic opioid therapy. Pain 152: 1256-1262.
59. Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R (2011) Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 30: 236-245.
60. Morris LS, Schulz R (1992) Patient compliance-an overview. J Clin Pharm Ther 17: 283-295.
61. Katz NP, Sherburne S, Beach M, Rose RJ, Vielguth J, Bradley J, Ganciullo GJ (2003) Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 97: 1097-1102.
62. Grattan A, Sullivan M, Saunders K, Campbell C, VonKorff M (2012) Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med 10: 304-311.
63. Porucznik C, Sauer B, Johnson E, Crook J, Wrathall J, Anderson J, Rolfs R (2010) Adult use of prescription opioid pain medications-Utah, 2008. MMWR 59: 153-157.
64. McCabe S, West B, Cranford J, Ross-Durow P, Young A, Teter C, Boyd C (2011) Medical misuse of controlled medications among adolescents. Arch Pediatr Adolesc Med 165: 729-735.
65. Passik S, Kirsh K, Whitcomb L, Dickerson P, Theobald D (2002) Pain clinicians' rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharm 16: 39-49.
66. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS (2008) What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 9: 444-459.
67. Boscarino J, Rukstalis M, Hoffman S, Han J, Erlich P, Gerhard G, Stewart W (2010) Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 105: 1776-1782.
68. Boscarino J, Rukstalis M, Hoffman R, Han J, Erlich P, Ross S, Gerhard G, Stewart W (2011) Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 30: 185-194.
69. Sullivan M, Edlund MJ, Fan M, DeVries A, Braden JB, Martin BC (2010) Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain 150: 332-339.
70. Couto JE, Romeny M, Leider H, Sharma S, Goldfarb N (2009) High rates of inappropriate drug use in the chronic pain population. Popul Health Manag 12: 185-190.
71. Michna E, Jamison RN, Pham L, Ross EL, Janfaza D, Nedeljkovic SS (2007) Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 23: 173-179.
72. Substance Abuse and Mental Health Services Administration (2011) Results from the 2010 National Survey on Drug Use and Health: detailed tables. NSDUH Series H-41. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Rockville.
73. Jones C (2012) Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010. Arch Intern Med.
74. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI (2009) Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 18: 1166-1175.